SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-088946
Filing Date
2023-11-21
Accepted
2023-11-21 08:00:23
Documents
2
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea188701-6k_altamira.htm 6-K 20497
2 SHARE PURCHASE AGREEMENT, DATED NOVEMBER 17, 2023, BY AND BETWEEN AURIS MEDICAL ea188701ex2-1_altamira.htm EX-2.1 204010
  Complete submission text file 0001213900-23-088946.txt   225857
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 231424535
SIC: 2834 Pharmaceutical Preparations